FRI0075 Rheumatoid Arthritis Patients Receiving Glucocorticoid Exhibits Significant Bone Quality Abnormalities, Leading to Severe Bone Fragility Regardless of Bisphosphonate Treatment

doi 10.1136/annrheumdis-2017-eular.3514
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Mechanisms of Bone Fragility in a Mouse Model of Glucocorticoid-Treated Rheumatoid Arthritis: Implications for Insufficiency Fracture Risk

Arthritis & Rheumatism
2012English

Significant Improvement of Bone Mineral Density and Bone Turnover Markers by Denosumab Therapy in Bisphosphonate-Unresponsive Patients

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2016English

Serum Serotonin Levels and Bone in Rheumatoid Arthritis Patients

Rheumatology International
RheumatologyAllergyImmunology
2017English

Bone Mineral Density in Patients With Early- Onset Rheumatoid Arthritis

Medical Journal of Bakirkoy
Medicine
2020English

Flowcytometric Analysis of Bone Marrow Cells From Patients With Rheumatoid Arthritis.

Ensho
1993English

Does Anti-TNF Therapy Cause a Less Significant Fall in Bone Mineral Density in Patients With Rheumatoid Arthritis?

The Internet Journal of Rheumatology
2011English

Low Doses Glucocorticoid Effect on Joint Destruction and Mineral Bone Density in Early Rheumatoid Arthritis

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2003English

MSX-1 Is Suppressed in Bisphosphonate-Exposed Jaw Bone Analysis of Bone Turnover-Related Cell Signalling After Bisphosphonate Treatment

Oral Diseases
OtorhinolaryngologyDentistry
2011English

Bone and TNF in Rheumatoid Arthritis: Clinical Implications

RMD Open
RheumatologyAllergyImmunology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy